Deutsche Bank
PASG icon

Deutsche Bank’s Passage Bio PASG Stock Holding History

Deutsche Bank’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,235
Closed -$23.2K – 3791
2023
Q2 		$23.2K Hold
1,235
– – ﹤0.01% 3565
2023
Q1 		$23.7K Hold
1,235
– – ﹤0.01% 3697
2022
Q4 		$34.1K Hold
1,235
– – ﹤0.01% 3672
2022
Q3 		$31K Sell
1,235
-874
-41% -$34.4K ﹤0.01% 3698
2022
Q2 		$99K Sell
2,109
-133
-6% -$6.21K ﹤0.01% 3531
2022
Q1 		$139K Sell
2,242
-120
-5% -$9.89K ﹤0.01% 3452
2021
Q4 		$300K Sell
2,362
-548
-19% -$89.5K ﹤0.01% 3152
2021
Q3 		$580K Buy
2,910
+20
+0.7% +$4.77K ﹤0.01% 2926
2021
Q2 		$766K Buy
2,890
+1,946
+206% +$602K ﹤0.01% 2952
2021
Q1 		$330K Buy
944
+51
+6% +$21.8K ﹤0.01% 3354
2020
Q4 		$456K Buy
893
+527
+144% +$211K ﹤0.01% 2970
2020
Q3 		$96K Buy
366
+33
+10% +$11.4K ﹤0.01% 3571
2020
Q2 		$182K Buy
+333
New +$150K ﹤0.01% 3183

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Deutsche Bank's PASG Position: Q3 2023 in Review

Deutsche Bank sold out of Passage Bio (PASG) in Q3 2023, closing a stake of 1,235 shares — an estimated $23.2K sold.

Deutsche Bank first reported a position in PASG in Q2 2020 and held it in 13 quarters. The position peaked at $766K in Q2 2021. 48 funds tracked by Wall St. Rank hold PASG as of Q3 2023.

  • Deutsche Bank reported no remaining Passage Bio position as of Q3 2023 after selling out during the quarter.
  • Deutsche Bank sold 1,235 Passage Bio shares in Q3 2023, an estimated $23.2K.
  • Deutsche Bank first reported a position in Passage Bio in Q2 2020 and held it in 13 quarters.
  • Deutsche Bank's Passage Bio position peaked at $766K in Q2 2021.
  • 48 funds tracked by Wall St. Rank held Passage Bio as of Q3 2023.

Based on Deutsche Bank's 13F filing for Q3 2023, filed 9 Nov 2023.